Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using 23 Na‐MRI at 3 T
NMR in Biomedicine · 2026-08 · 39 (8)
DOI: 10.1002/nbm.70338 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 24.06.2026. Verfasst von Ines Horvat-Menih und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Kidney Neoplasms, Sodium, Magnetic Resonance Imaging. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Cancer Research UK Cambridge Institute, University of Cambridge, NIHR Cambridge Biomedical Research Centre.
Abstract (Originalsprache)
Accurate and non‐invasive subtyping of localised renal tumours is an important unmet clinical challenge in uro‐oncology and has significant implications for patient mortality and quality of life. Developing novel imaging methods to characterise and stratify indeterminate kidney tumours at an early stage has the potential to address this clinical challenge. Here we applied sodium MRI ( 23 Na‐MRI) to estimate kidney tumour sodium content in a prospectively recruited case series of 10 patients (mean age ± SD 64 ± 8 years; 7:3 male:female ratio). The patients had localised renal tumours which included six renal oncocytomas (ROs), two chromophobe renal cell carcinomas (chRCCs), three clear cell RCCs (ccRCC) and one papillary RCC (pRCC). The patients underwent 23 Na‐MRI at 3 T (3D sodium cones and double‐angle B 1 mapping) and 1 H‐MRI which included R 2 * mapping and intravoxel incoherent motion (IVIM) diffusion weighted imaging (DWI). The following imaging parameters were quantified within the renal tumours and in the normal‐appearing kidney parenchyma: apparent total sodium concentration (TSC); apparent 23 Na and 1 H relaxation rates ( R 2 *); perfusion fraction ( f p ); and diffusion coefficient ( D t ). 23 Na‐MRI findings were correlated with conventional 1 H‐MRI measures of perfusion, hypoxia and cellularity. The mean apparent TSC in ccRCC and in pRCC were 135 ± 59 mM and 81 mM, respectively. The apparent TSC was significantly higher in ROs compared to chRCCs: 162 ± 58 mM vs. 71 ± 2 mM ( p < 0.05). The apparent TSC inversely correlated with 1 H‐ R 2 * (Spearman r = −0.39, p < 0.05). In conclusion, this study showed the feasibility and potential of using 23 Na‐MRI in renal tumours to probe sodium concentrations. These preliminary findings suggest a differential sodium content between benign ROs and malignant chRCCs. The inverse correlation between sodium concentration and 1 H‐ R 2 * as a surrogate of hypoxia may indicate a biophysical relationship between the two which requires further validation in larger patient cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of Cambridge, Cambridge, UK.
- Mohn Medical Imaging and Visualization Centre, Department of Radiology, Haukeland University Hospital Helse Bergen, Bergen, Norway.
- Department of Radiology, Royal Papworth Hospital, Cambridge, UK.
- Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
- Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
ORCID-Profile: Ines Horvat-Menih, Jonathan R Birchall, Joshua D Kaggie, James Jones, Thomas J Mitchell, Grant D Stewart, Ferdia A Gallagher
Förderung
- Cancer Research UK
- Cancer Research UK Cambridge Institute, University of Cambridge
- NIHR Cambridge Biomedical Research Centre
- Mark Foundation for Cancer Research
- National Cancer Imaging Translational Accelerator
- Cambridge Experimental Cancer Medicine Centre
- Mark Foundation Institute for Integrated Cancer Medicine
- Canadian Institute For Advanced Research
Zitieren
APA
Horvat-Menih, I., Birchall, J. R., Zamora-Morales, M. J., Bebb, A., Kaggie, J. D., Riemer, F., Gill, A. B., Priest, A. N., Wylot, M., Mendichovszky, I. A., Warren, A. Y., Jones, J., Armitage, J. N., Mitchell, T. J., Stewart, G. D., McLean, M. A., & Gallagher, F. A. (2026). Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using 23 Na‐MRI at 3 T. NMR in Biomedicine, 39(8). https://doi.org/10.1002/nbm.70338
Vancouver
Horvat-Menih I, Birchall JR, Zamora-Morales MJ, Bebb A, Kaggie JD, Riemer F, et al. Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using 23 Na‐MRI at 3 T. NMR in Biomedicine. 2026;39(8). doi:10.1002/nbm.70338
BibTeX
@article{HorvatMenih2026,
author = {Horvat-Menih, Ines and Birchall, Jonathan R and Zamora-Morales, Maria J and Bebb, Alice and Kaggie, Joshua D and Riemer, Frank and Gill, Andrew B and Priest, Andrew N and Wylot, Marta and Mendichovszky, Iosif A and Warren, Anne Y and Jones, James and Armitage, James N and Mitchell, Thomas J and Stewart, Grant D and McLean, Mary A and Gallagher, Ferdia A},
title = {Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using 23 Na‐MRI at 3 T},
journal = {NMR in Biomedicine},
year = {2026},
volume = {39},
number = {8},
doi = {10.1002/nbm.70338}
}
EUVIMED